Filing Details

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 13D/A

(Amendment No. 3)*

Under the Securities Exchange Act of 1934

 

Rx Safes, Inc.

(Name of Issuer)

 

Common Stock, $0.001 Par Value

(Title of Class of Securities)

 

78348J105

(CUSIP Number)

 

Lorraine Yarde

RX Safes, Inc.

170 Green Valley Parkway, Suite 300

Henderson, NV 89012

 (Name, Address and Telephone Number of Person

Authorized to Receive Notices and Communications)

 

January 1, 2015

(Date of Event which Requires Filing of this Statement)

 

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box o

 

NOTE: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See § 240.13d-7 for other parties to whom copies are to be sent.

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

CUSIP No.: 78348J105

Schedule 13D/A

 

1	NAMES OF REPORTING PERSONS. I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (Entities Only):   Lorraine Yarde
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)       (a) [ ]     (b) [ ]
3	SEC USE ONLY
4	SOURCE OF FUNDS (See Instructions)   PF
5	CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [ ]
6	CITIZENSHIP OR PLACE OF ORGANIZATION   United States
NUMBER OF SHARES		7	SOLE VOTING POWER   140,028,132 (1)
BENEFICIALLY OWNED BY EACH		8	SHARED VOTING POWER   0
REPORTING PERSON  WITH		9	SOLE DISPOSITIVE POWER   71,123,132 (2)
		10	SHARED DISPOSITIVE POWER   0
11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON   71,123,132
12	CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)   [ ]
13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)   87% (3)
14	TYPE OF REPORTING PERSON (See Instructions)   IN

 

 

(1)

Includes 1,428,132 shares of common stock of the Issuer held in her name, and 693 shares of Series B Preferred Stock of the Issuer held in her name that have the right to cast 200,000 votes for each share held of record on all matters submitted to a vote of holders of the Issuer’s common stock.

(2)

Includes 1,428,132 shares of common stock of the Issuer held in her name, options to purchase 75,000 shares of the Issuer’s common stock, accrued compensation that she is able to convert into 320,000 shares of commons stock and 693 shares of Series B Preferred Stock of the Issuer that may be converted into 69,300,000 shares of common stock of the Issuer.

(3)

Based on a total of 11,761,102 shares of the Issuer’s common stock outstanding as of May 18, 2016, as stated in the Issuer’s Form 10-Q filed on May 23, 2016, including the derivative securities set forth in Note 2 above which are deemed outstanding for purposes of computing the percentage of outstanding securities on this Schedule 13D/A.

 

This Schedule 13D Amendment No. 2 (this “Schedule 13D/A”) amends the following sections of the Schedule 13D filed with the Securities and Exchange Commission (“SEC”) on February 25, 2015 (the “Schedule 13D”), the Schedule 13D Amendment No. 1 filed with the SEC on October 19, 2015 and the Schedule 13D Amendment No. 2 filed with the SEC on February 19, 2016.

 

Item 2.  IDENTITY AND BACKGROUND.

 

This Schedule 13D/A is being filed by Lorraine Yarde, a citizen of the United States of America (the “Reporting Person”). The Reporting Person serves as a director and Chief Executive Officer of the Company. The Reporting Person’s business address is c/o RX Safes, Inc. 170 Green Valley Parkway, Suite 300 Henderson, NV 89012.

 

During the last ten years, the Reporting Person has not been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) or been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding, was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

 

Item 3.  SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.

 

Item 3 of Schedule 13D is supplemented and amended by the information below.

 

Effective January 1, 2015, the Issuer issued a two year option to purchase 12,500 shares to the Reporting Person at an exercise price of $0.001 per share.

 

Effective January 1, 2016, the Issuer issued a two year option to purchase 12,500 shares to the Reporting Person at an exercise price of $0.001 per share.

 

Item 5.  INTEREST IN SECURITIES OF THE ISSUER.

 

Item 5 of Schedule 13D is supplemented and amended by the information below.

 

Reference is made to the disclosure set forth under Item 3 of this Schedule 13D/A, which disclosure is incorporated herein by reference.

 

Item 6.  CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO SECURITIES OF THE ISSUER.

 

Reference is made to the disclosure set forth under Items 3 and 5 of this Schedule 13D/A, which disclosure is incorporated herein by reference.

 

SIGNATURES

 

After reasonable inquiry and to the best of the undersigned's knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.

 

Date: July 8, 2016	By:	/s/ Lorraine Yarde
		Lorraine Yarde